Compounded Bioidentical Hormone Therapy Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Awareness Amongst People
- Increasing Cases of Thyroid, Insulin Resistance, and Osteoporosis
Challenges
- Associated Health Hazards with Hormone Therapy
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
The compounded bioidentical hormone therapy industry size is expected to register around 5.2% CAGR during the forecast period i.e., between 2025-2037.
The market growth is propelled by increasing health awareness amongst the people.
North America industry is expected to account for largest revenue share by 2037, on the back of higher healthcare expenditure, increasing thyroid prevalence amongst women, and more awareness amongst the people.
The major players in the market are Defy Medical, LLC, The biostation, Noven Pharmaceuticals, Inc., Novartis AG, and Pfizer Inc.
